Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
- Citation:
- Neuro Oncol vol 14 (2) 215-221
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 1
- Parents:
- 638
- Children:
- None
- Pharmas:
- Grants:
- R01 CA 154348, U10 CA 25224
- Corr. Author:
- Authors:
- Bret B. Friday S. Keith Anderson Jan Buckner Chunrong Yu Caterina Giannini Francois Geoffroy John Schwerkoske Miroslaw Mazurczak Howard Gross Eduardo Pajon Kurt Jaeckle Evanthia Galanis
- Networks:
- Study
- NCCTG-N0779
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- bortezomib, phase II trial, recurrent glioblastoma, vorinostat